DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

Chimerix (NASDAQ: CMRX)

22.46 0.04 (0.18%)

Quote as of


company name or ticker

Recent Quotes

CMRX $22.46 0.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.16
Previous Close $22.42
Daily Range $22.07 - $22.66
52-Week Range $12.96 - $27.69
Market Cap $605.6M
P/E Ratio 1.21
Dividend (Yield) $0.00 (0.0%)
Volume 213,483
Average Daily Volume 304,797
Current FY EPS -$1.78

Sector

Industry

Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website: http://www.chimerix.com/

News & Commentary

Why Chimerix Inc. Shares Jumped

Chimerix delivers a narrower-than-expected third-quarter loss, but here's what shareholders should really have their eyes on.

Thursday 5/29 Insider Buying Report: GLAD, CMRX

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Weakness Seen in Chimerix (CMRX): Stock Tanks 15.5% - Tale of the Tape

Why Chimerix (CMRX) Stock Is Up Today

What Makes Chimerix (CMRX) a Strong Sell? - Tale of the Tape

Chimerix's (CMRX) CEO Michelle Berrey on Q1 2014 Results - Earnings Call Transcript

Chimerix Is Now Oversold (CMRX)

Increased Earnings Estimates Seen for Chimerix (CMRX): Can It Move Higher? - Tale of the Tape

Chimerix: A Company Focused On Infectious Viral Diseases With Investment Characteristics Similar To

Chimerix: A Company Focused On Infectious Viral Diseases With Investment Characteristics Similar To Trius

Strength Seen in Chimerix (CMRX): Stock Soars 18.2% - Tale of the Tape

See More CMRX News...